vs
BXP, Inc.（BXP）与ICU MEDICAL INC（ICUI）财务数据对比。点击上方公司名可切换其他公司
BXP, Inc.的季度营收约是ICU MEDICAL INC的1.6倍（$872.1M vs $540.7M），BXP, Inc.净利率更高（15.3% vs -2.9%，领先18.2%），BXP, Inc.同比增速更快（0.8% vs -14.1%），过去两年BXP, Inc.的营收复合增速更高（1.3% vs -2.3%）
BXP是美国头部商业地产投资信托企业，核心业务为持有、运营及开发A级高端写字楼资产，项目覆盖纽约、波士顿、旧金山等美国核心都市圈，服务企业、科技、专业服务等领域的多元租户。
ICU医疗是总部位于美国加利福尼亚州圣克莱门特的医疗科技企业，专注于研发预防血流感染、保护医护人员免受传染病或危险药物侵害的医疗产品，产品线覆盖静脉治疗用品、输液泵、无针血管通路设备、定制输液套装、危险药物密闭处理系统、传感导管以及无针封闭式血液采样系统等。
BXP vs ICUI — 直观对比
营收规模更大
BXP
是对方的1.6倍
$540.7M
营收增速更快
BXP
高出14.9%
-14.1%
净利率更高
BXP
高出18.2%
-2.9%
两年增速更快
BXP
近两年复合增速
-2.3%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $872.1M | $540.7M |
| 净利润 | $133.0M | $-15.7M |
| 毛利率 | — | 37.5% |
| 营业利润率 | — | 1.0% |
| 净利率 | 15.3% | -2.9% |
| 营收同比 | 0.8% | -14.1% |
| 净利润同比 | 53.0% | 34.0% |
| 每股收益（稀释后） | $1.69 | $-0.63 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BXPICUI
| Q1 26 | $872.1M | — | ||
| Q4 25 | $877.1M | $540.7M | ||
| Q3 25 | $871.5M | $537.0M | ||
| Q2 25 | $868.5M | $548.9M | ||
| Q1 25 | $865.2M | $604.7M | ||
| Q4 24 | $858.6M | $629.8M | ||
| Q3 24 | $859.2M | $589.1M | ||
| Q2 24 | $850.5M | $596.5M |
净利润BXPICUI
| Q1 26 | $133.0M | — | ||
| Q4 25 | $248.4M | $-15.7M | ||
| Q3 25 | $-121.7M | $-3.4M | ||
| Q2 25 | $89.0M | $35.3M | ||
| Q1 25 | $61.2M | $-15.5M | ||
| Q4 24 | $-228.9M | $-23.8M | ||
| Q3 24 | $83.6M | $-33.0M | ||
| Q2 24 | $79.6M | $-21.4M |
毛利率BXPICUI
| Q1 26 | — | — | ||
| Q4 25 | 58.8% | 37.5% | ||
| Q3 25 | 59.3% | 37.4% | ||
| Q2 25 | 59.2% | 37.9% | ||
| Q1 25 | 59.2% | 34.7% | ||
| Q4 24 | 59.7% | 36.1% | ||
| Q3 24 | 59.5% | 34.8% | ||
| Q2 24 | 59.8% | 34.8% |
营业利润率BXPICUI
| Q1 26 | — | — | ||
| Q4 25 | — | 1.0% | ||
| Q3 25 | — | 2.6% | ||
| Q2 25 | — | 1.9% | ||
| Q1 25 | — | 2.1% | ||
| Q4 24 | — | 6.0% | ||
| Q3 24 | — | 1.4% | ||
| Q2 24 | — | 1.3% |
净利率BXPICUI
| Q1 26 | 15.3% | — | ||
| Q4 25 | 28.3% | -2.9% | ||
| Q3 25 | -14.0% | -0.6% | ||
| Q2 25 | 10.2% | 6.4% | ||
| Q1 25 | 7.1% | -2.6% | ||
| Q4 24 | -26.7% | -3.8% | ||
| Q3 24 | 9.7% | -5.6% | ||
| Q2 24 | 9.4% | -3.6% |
每股收益（稀释后）BXPICUI
| Q1 26 | $1.69 | — | ||
| Q4 25 | $1.56 | $-0.63 | ||
| Q3 25 | $-0.77 | $-0.14 | ||
| Q2 25 | $0.56 | $1.43 | ||
| Q1 25 | $0.39 | $-0.63 | ||
| Q4 24 | $-1.46 | $-0.97 | ||
| Q3 24 | $0.53 | $-1.35 | ||
| Q2 24 | $0.51 | $-0.88 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $512.8M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $7.7B | $2.1B |
| 总资产 | $25.1B | $4.1B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资BXPICUI
| Q1 26 | $512.8M | — | ||
| Q4 25 | $1.5B | — | ||
| Q3 25 | $861.1M | — | ||
| Q2 25 | $447.0M | — | ||
| Q1 25 | $398.1M | — | ||
| Q4 24 | $1.3B | $308.6M | ||
| Q3 24 | $1.4B | $312.5M | ||
| Q2 24 | $685.4M | $302.6M |
股东权益BXPICUI
| Q1 26 | $7.7B | — | ||
| Q4 25 | $5.1B | $2.1B | ||
| Q3 25 | $5.0B | $2.1B | ||
| Q2 25 | $5.3B | $2.1B | ||
| Q1 25 | $5.3B | $2.0B | ||
| Q4 24 | $5.4B | $2.0B | ||
| Q3 24 | $5.8B | $2.0B | ||
| Q2 24 | $5.8B | $2.0B |
总资产BXPICUI
| Q1 26 | $25.1B | — | ||
| Q4 25 | $26.2B | $4.1B | ||
| Q3 25 | $26.0B | $4.1B | ||
| Q2 25 | $25.6B | $4.1B | ||
| Q1 25 | $25.4B | $4.2B | ||
| Q4 24 | $26.1B | $4.2B | ||
| Q3 24 | $26.4B | $4.3B | ||
| Q2 24 | $25.5B | $4.3B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $60.6M |
| 自由现金流经营现金流 - 资本支出 | — | $36.0M |
| 自由现金流率自由现金流/营收 | — | 6.6% |
| 资本支出强度资本支出/营收 | 1.5% | 4.6% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $91.8M |
8季度趋势，按日历期对齐
经营现金流BXPICUI
| Q1 26 | — | — | ||
| Q4 25 | $407.8M | $60.6M | ||
| Q3 25 | $274.2M | $56.7M | ||
| Q2 25 | $353.1M | $11.2M | ||
| Q1 25 | $210.0M | $51.3M | ||
| Q4 24 | $383.7M | $40.2M | ||
| Q3 24 | $286.1M | $36.1M | ||
| Q2 24 | $367.1M | $82.0M |
自由现金流BXPICUI
| Q1 26 | — | — | ||
| Q4 25 | $362.7M | $36.0M | ||
| Q3 25 | $231.6M | $27.6M | ||
| Q2 25 | $281.5M | $-8.5M | ||
| Q1 25 | $152.6M | $36.7M | ||
| Q4 24 | $312.5M | $16.1M | ||
| Q3 24 | $234.5M | $16.2M | ||
| Q2 24 | $332.4M | $62.5M |
自由现金流率BXPICUI
| Q1 26 | — | — | ||
| Q4 25 | 41.4% | 6.6% | ||
| Q3 25 | 26.6% | 5.1% | ||
| Q2 25 | 32.4% | -1.5% | ||
| Q1 25 | 17.6% | 6.1% | ||
| Q4 24 | 36.4% | 2.6% | ||
| Q3 24 | 27.3% | 2.7% | ||
| Q2 24 | 39.1% | 10.5% |
资本支出强度BXPICUI
| Q1 26 | 1.5% | — | ||
| Q4 25 | 5.1% | 4.6% | ||
| Q3 25 | 4.9% | 5.4% | ||
| Q2 25 | 8.2% | 3.6% | ||
| Q1 25 | 6.6% | 2.4% | ||
| Q4 24 | 8.3% | 3.8% | ||
| Q3 24 | 6.0% | 3.4% | ||
| Q2 24 | 4.1% | 3.3% |
现金转化率BXPICUI
| Q1 26 | — | — | ||
| Q4 25 | 1.64× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 3.97× | 0.32× | ||
| Q1 25 | 3.43× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 3.42× | — | ||
| Q2 24 | 4.61× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BXP
| Lease | $818.2M | 94% |
| Parking and other | $30.8M | 4% |
| Development and management services | $9.2M | 1% |
ICUI
| Infusion Consumables | $284.7M | 53% |
| Infusion Systems | $176.3M | 33% |
| Vital Care | $79.7M | 15% |
